A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers

Documenti analoghi

• Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers
  di: Pan Luo, et al.
  Pubblicazione: (2026)
• Pharmacokinetics and Bioequivalence of Vardenafil Hydrochloride in Healthy Chinese Volunteers
  di: Sheng He, et al.
  Pubblicazione: (2024)
• Safety, Tolerability, and Pharmacokinetics of Voriconazole for Injection in Two Preparations in Chinese Healthy Adult Volunteers
  di: Jin Yu, et al.
  Pubblicazione: (2024)
• Bioequivalence of Meloxicam Nanocrystal Injection in Healthy Chinese Volunteers
  di: Shengling Hu, et al.
  Pubblicazione: (2024)
• Bioequivalence and Pharmacokinetic Evaluation of Regorafenib Tablets in Healthy Chinese Volunteers
  di: Zhaoyu Wang, et al.
  Pubblicazione: (2024)